Cempra Inc (NASDAQ: CEMP) is likely to have a strong day in the market today. Early this morning, the stock was halted ahead of news that the company has entered into a definitive merger agreement. Of course this is likely to lead to excitement among investors. Before we get into the details, we’d like to … Read more
Cempra Inc (NASDAQ: CEMP) Cempra is having an overwhelmingly strong day in the market today. At the opening bell, the stock was already trading with impressive gains. Since the bell, we’ve seen a bit of movement in both directions, but the stock is still holding onto the profits. Below, we’ll talk about what we’re seeing … Read more
Cempra Inc (NASDAQ: CEMP) Well, tick, tock went the clock for CEMP as CNA Finance covered yesterday, but unfortunately for CEMP, time appears to have run out on its solithromycin NDA. On Thursday, CEMP said that they have received a complete response letter from the FDA regarding its NDA for solithromycin, a treatment for community-acquired … Read more
Cempra Inc (NASDAQ: CEMP) Cempra Inc. is essentially all-in at this point in time, with two vitally important PFUDA reviews pending this week for solithromycin, its drug intended to treat community-acquired bacterial pneumonia. We received a trading tool, news alert from Trade Ideas that brought our focus to CEMP. The FDA is set to render … Read more
Cempra Inc (NASDAQ: CEMP) Cempra is having an incredibly strong day in the market today. Since the opening bell, the stock has traded well in the green, and it doesn’t look to be giving up the gains any time soon. Below, we’ll talk about what we’re seeing from the stock, why, and what we’ll be … Read more
US stocks have had an incredibly rough time in the market this week. Mid last week, the Federal Reserve made a statement that they would not be aggressive in increasing interest rates. While the lack of aggression made investors happy short term, it seems as though reality set in early this week as the Dow … Read more